With 35% of Americans having prediabetes, prevention is clearly a priority, but many strategies have not bee translated into clinical practice because there is no system for reimbursement yet, explained Paul Chew, MD, chief medical officer of Omada Health
With 35% of Americans having prediabetes, prevention is clearly a priority, but many strategies have not bee translated into clinical practice because there is no system for reimbursement yet, explained Paul Chew, MD, chief medical officer of Omada Health
Transcript
With more than 30 million American with diabetes, prevention clearly needs to be a priority, but there is a lack of provider awareness about available options. How can payers work with providers to build awareness about prevention?
What’s not known is that 12% of Americans have diabetes, and 35% have prediabetes. It’s even more amazing is that 90% of those who have prediabetes don’t know it. The problem we have is that there’s lot of clinical literature which shows that behavioral counseling and dietary management can reduce the incidence of diabetes incidence in those at risk by more than half. The problem we have is not the lack of literature, but the fact that it has not been translated into practice for the benefit of people and to prevent them from becoming patients.
The main reason is that there is a system that has not been reimburse or recognizing the value of prevention. The other issue is that this problem is so massive, with more than 84 million Americans having prediabetes, that it is literally impossible to address it in the old traditional way. So, we need proven digital approaches, one where return on investment and publications can validate these approaches to make this a reality. Finally, one of the bright spots is that CMS will be encouraging predicates testing and prediabetes referrals, so that sort of alignment of the medical need and the incentives and benefits can be brought closer into harmony.
Has the implementation of MACRA increased provider awareness or sped adoption of prevention strategies?
One of the most significant advances for the problem of prediabetes will be the MACRA (Medicare Access and CHIP Reauthorization Act) and MIPS (Merit-Based Incentive Payment System) incentive for referral to programs—validated Diabetes Prevention Programs—as well as testing for prediabetes through the MACRA and MIPS initiatives. People at risk for diabetes live all over the country; some are closer to Diabetes Prevention Programs than others. And so, to reach the more than 80 mi people at risk we need a comb of both face-to-face as well as digital programs. So, face-to-face and digital in the setting of MACRA and MIPS can greatly accelerate the treatment of people with prediabetes.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More